文献速递造血干细胞移植与细胞治疗

通过不同肠道区域微生物组和代谢组模式揭示移植物抗宿主病的新型调控因子

Novel regulators of GVHD revealed through microbiome and metabolome patterns across distinct intestinal regions.
PubMed 文献 · Blood · 2025-01-01

研究采用多组学方法,在充分表征的小鼠移植物抗宿主病(GVHD)模型中分析不同肠道区域内容物的微生物组和代谢物谱,验证了粪便分析结果,并发现同基因与异基因宿主间随肠道位置和移植后时间变化的微生物及代谢物差异,确认短链脂肪酸合成和胆汁酸代谢等已知通路参与,鉴定出氨基酸、脂肪酸和鞘脂等新功能基因、通路和代谢物,并验证了苯乳酸与胃肠道GVHD的生物学相关性。

要点

  • 小鼠GVHD模型中不同肠道区域的微生物组和代谢组存在地理变异,粪便分析不能完全反映肠道各段变化。
  • 整合分析确认短链脂肪酸合成和胆汁酸代谢通路参与胃肠道GVHD,并发现氨基酸、脂肪酸和鞘脂等新通路和代谢物。
  • 新鉴定的微生物代谢物苯乳酸被验证与胃肠道GVHD存在生物学相关性。

核心结论

  • 肠道微生物组和代谢组的地理变异为胃肠道GVHD发病机制提供新见解,并具有新型治疗潜力。

研究设计与样本

  • 研究采用多组学方法,在充分表征的小鼠GVHD模型中分析不同肠道区域内容物的微生物组和代谢物谱。

主要发现

  • 分析验证了粪便排泄物的分析结果,并发现同基因与异基因宿主间微生物和代谢物变化随肠道位置和移植后时间而异。
  • 整合分析确认短链脂肪酸合成和胆汁酸代谢等已知代谢通路参与,并鉴定出氨基酸、脂肪酸和鞘脂等额外功能基因、通路和代谢物与胃肠道GVHD相关。
  • 验证了新鉴定的微生物代谢物苯乳酸与胃肠道GVHD的生物学相关性,此前未将其与胃肠道GVHD关联。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Microbial dysbiosis and metabolite changes in the gastrointestinal (GI) tract have been linked to pathogenesis and severity of many diseases, including graft-versus-host disease (GVHD), the major complication of allogeneic hematopoietic stem cell transplantation. However, published studies have only considered the microbiome and metabolome of excreted stool and do not provide insight into the variability of the microbial community and metabolite composition throughout the GI tract or the unique temporal dynamics associated with different gut locations. Because such geographical variations are known to influence disease processes, we used a multi-omics approach to characterize the microbiome and metabolite profiles of gut contents from different intestinal regions in well-characterized mouse models of GVHD. Our analysis validated analyses from excreted stool, but importantly, uncovered new biological insights from the microbial and metabolite changes between syngeneic and allogeneic hosts that varied by GI location and time after transplantation. Our integrated analysis confirmed the involvement of known metabolic pathways, including short-chain fatty acid synthesis and bile acid metabolism, and identified additional functional genes, pathways, and metabolites, such as amino acids, fatty acids, and sphingolipids, linked to GI GVHD. Finally, we validated a biological relevance for one such newly identified microbial metabolite, phenyl lactate, that heretofore had not been linked to GI GVHD. Thus, our analysis of the geographic variability in the intestinal microbiome and metabolome offers new insights into GI GVHD pathogenesis and potential for novel therapeutics.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Lauder E, Kiledal EA, Maneix L, et al. Novel regulators of GVHD revealed through microbiome and metabolome patterns across distinct intestinal regions. Blood. 2025. PMID: 40009444. doi:10.1182/blood.2024025924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。